Literature DB >> 27190847

Role of Frequency Doubled Nd: Yag Laser in Treatment of Corneal Neovascularisation.

Jitendra Kumar1, Aakanksha Gehra2, Naveen Sirohi2.   

Abstract

INTRODUCTION: Cornea is the outermost transparent coat of eye along with sclera, for which its avascularity is essential for maintaining its transparency to have normal visual acuity. Corneal neovascularization is characterized by the invasion of new blood vessels into the cornea from the limbus interfering with corneal transparency, resulting in reduction in visual acuity. It also increases the risk of graft rejection. So their being a dire need to treat corneal neovascularisation, with laser photocoagulation being an effective means of treating it. AIM: To evaluate the efficacy and safety of frequency doubled Nd:Yag laser photocoagulation in treatment of corneal neovascularisation.
MATERIALS AND METHODS: A single centre prospective study was carried out on patients attending the outpatient department of ophthalmology in Maharani Laxmi Bai Medical College, Jhansi. Forty eyes of 40 patients having corneal neovascularisation with quiescent eyes satisfying the inclusion criteria were selected and treated with laser. The efficacy of the procedure was noted in terms of area of corneal neovascularisation, status of treated vessels, area of corneal opacity, visual acuity. The above parameters of selected patients were recorded before treatment and subsequent follow up visits at 1 week, 1 month, 2 month and 3 month after laser. Paired t-test was used to calculate the p-value.
RESULTS: There was a statistically significant difference in the percentage mean area of corneal neovascularisation with a pre laser value of 31.93% to 17.62% after 3 months of laser treatment (p-value<0.0001). The percentage mean area of corneal opacity decreased from 30.75% to 23.74% (p<0.0001). Out of 185 corneal vessels, 99 (53.51%) vessels were completely occluded,17(9.18%) vessels were partially occluded and 69(37.29%) vessels were recanalised at the end of 3 months after laser treatment.
CONCLUSION: Frequency doubled Nd:Yag laser is an effective and safe method for the treatment of corneal neovascularisation.

Entities:  

Keywords:  Avascularity; Corneal opacity; Graft rejection; Visual acuity

Year:  2016        PMID: 27190847      PMCID: PMC4866145          DOI: 10.7860/JCDR/2016/17502.7543

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Effect of cortisone on vascularization and opacification of the cornea induced by alloxan.

Authors:  N ASHTON; C COOK; M LANGHAM
Journal:  Br J Ophthalmol       Date:  1951-11       Impact factor: 4.638

3.  Fine needle diathermy occlusion of corneal vessels.

Authors:  C T Pillai; H S Dua; P Hossain
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

4.  A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.

Authors:  Hamid Hosseini; Mahmood Nejabat
Journal:  Med Hypotheses       Date:  2006-11-14       Impact factor: 1.538

5.  Frequency doubled Nd:YAG (532 nm) laser photocoagulation in corneal vascularisation: efficacy and time sequenced changes.

Authors:  A Sharma; A Samal; S Narang; A Gutpa; J Ram; A Gupta
Journal:  Indian J Ophthalmol       Date:  2001-12       Impact factor: 1.848

6.  Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.

Authors:  Manuela Banciu; Josbert M Metselaar; Raymond M Schiffelers; Gert Storm
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

7.  Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer.

Authors:  Baris Sonmez; Umit Beden; Dilek Erkan
Journal:  Int Ophthalmol       Date:  2007-12-20       Impact factor: 2.031

8.  Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.

Authors:  John D Sheppard; Randy J Epstein; Frank A Lattanzio; Domenica Marcantonio; Patricia B Williams
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

9.  Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs.

Authors:  Pouya Pakneshan; Amy E Birsner; Irit Adini; Christian M Becker; Robert J D'Amato
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

10.  Photodynamic therapy for corneal neovascularization.

Authors:  R J Epstein; R L Hendricks; D M Harris
Journal:  Cornea       Date:  1991-09       Impact factor: 2.651

View more
  5 in total

1.  Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization.

Authors:  Rui Zhang; Jingjing Yang; Qing Luo; Jieran Shi; Haohang Xu; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 3.  Therapeutic approaches for corneal neovascularization.

Authors:  Sepehr Feizi; Amir A Azari; Sharareh Safapour
Journal:  Eye Vis (Lond)       Date:  2017-12-10

4.  Photo-Mediated Ultrasound Therapy for the Treatment of Corneal Neovascularization in Rabbit Eyes.

Authors:  Yu Qin; Yixin Yu; Julia Fu; Xinyi Xie; Tao Wang; Maria A Woodward; Yannis M Paulus; Xinmai Yang; Xueding Wang
Journal:  Transl Vis Sci Technol       Date:  2020-12-09       Impact factor: 3.283

5.  Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α.

Authors:  Ying-Cong Fu; Zhi-Ming Xin
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.